ZimVie Inc
ZIMV
View Detailed Chart
18.900USD
+0.020+0.11%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
532.92MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.11%
5 Days
+0.11%
1 Month
-0.26%
6 Months
+57.24%
Year to Date
+35.48%
1 Year
+14.75%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated: 2025-09-18Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
4
analysts
Hold
Current Rating
16.000
Target Price
-15.25%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.
Undervalued
The company’s latest PE is -26.85, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 24.71M shares, decreasing 12.21% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.78M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.16.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.
Ticker SymbolZIMV
CompanyZimVie Inc
CEOMr. Vafa Jamali
Websitehttps://www.zimvie.com/en
Related Instruments
+0.30%
+0.25%
+1.07%
+0.61%
+0.43%
+2.29%
+0.76%
-0.86%
+0.69%
+3.50%
+0.29%
-0.65%
-0.75%
+4.51%
+0.41%
+2.11%
+0.57%
+2.42%
+1.75%
+1.25%
